| RUSH UNIVERSITY MEDICAL CENTER Patent applications |
| Patent application number | Title | Published |
|---|
| 20110232133 | JOINT LOAD REDUCING FOOTWEAR - Footwear including a flexible sole having a series of flexure zones positioned to correspond to primary joint axes of the human foot approximating the characteristics of a bare foot in motion. | 09-29-2011 |
| 20110185486 | Support for Wall Mounted Toilets - A support platform for wall mounted toilets is described. The platform attaches easily under the toilet and contains bolts and feet for adjustment. The platform provides support to wall mounted toilets so that persons of weight greater than the rated load of the wall mounted toilet can use the toilet in comfort and safety. It is removable for use in different bathrooms, easily transported and can be sterilized where bacterial or viral contamination is a concern. | 08-04-2011 |
| 20110153365 | SYSTEM AND METHOD OF MANAGING AND DOCUMENTING LACTATION DATA - A system and method of managing and documenting lactation data includes inputting patient lactation data, retrieving, editing, creating, or updating a database to include the patient lactation data in real time, and storing the patient lactation data in a database which can be centrally located to facilitate integration with other medical records. | 06-23-2011 |
| 20100331404 | Vector Delivery-Based Microbicides - A new class of anti-microbial agents and methods for preventing or reducing the risk of sexually transmitted infections and/or diseases is provided. Preferably, these anti-microbial agents are also contraceptive and, thus, also prevent or reduce the risk of unplanned pregnancies. The anti-microbial agents comprise a delivery vector having anti-microbial activity (and preferably contraceptive activity) coupled with a nitric oxide donor moiety. | 12-30-2010 |
| 20100274304 | METHOD AND DEVICE TO MANAGE FREEZING OF GAIT IN PATIENTS SUFFERING FROM A MOVEMENT DISORDER - The subject invention involves a device and method for treating patients with a movement disorder experiencing a sudden change in regularity of gait or akinesia, and comprising a device that detects the sudden change in regularity of gait or temporary akinesia and automatically issues a cue signal that restarts the movement. | 10-28-2010 |
| 20100267742 | COMBINATION TARGETED THERAPY FOR LUNG CANCER - A combination of compounds is described that target protein kinases and is more effective than the individual compounds against cancer where EGFR is upregulated and c-met is activated, for example, epithelial cell tumors, and particularly, non small cell lung carcinomas (NSCLC). | 10-21-2010 |
| 20100174372 | PLASTIC IMPLANT IMPREGNATED WITH A DEGRADATION PROTECTOR - A plastic implant device for a mammal that contains a rare earth metal compound tracer and a method for detecting degradation such as wear of the implanted device are disclosed. The tracer can also be present with a separate antioxidant or the tracer compound can be can be the salt of a C | 07-08-2010 |
| 20100143929 | DNA METHYLATION BASED TEST FOR MONITORING EFFICACY OF TREATMENT - A DNA methylation-based test for efficiency of treatments is based on a plurality of genes. The test is suitable for monitoring treatment of subjects with neurological diseases, e.g., multiple sclerosis (MS); with cancer, e.g., breast and ovarian cancer, and with other diseases for which methylation of biomarkers differs in the diseased compared to the non-diseased state. | 06-10-2010 |
| 20100010630 | PLASTIC IMPLANT IMPREGNATED WITH A DEGRADATION PROTECTOR - A plastic implant device for a mammal that contains a rare earth metal compound tracer and a method for detecting degradation such as wear of the implanted device are disclosed. The tracer can also be present with a separate antioxidant or the tracer compound can be can be the salt of a C | 01-14-2010 |
| 20080255049 | COMBINED USE OF ULTRASOUND AND GROWTH FACTORS TO STIMULATE BONE FORMATION - The combination of low intensity pulsed ultrasound with administration of an osteogenic protein or proteins or their genes enhances bone repair in mammals. This combination avoids thermal activation of tissue repair mechanisms and allows the osteogenic protein or proteins or their genes to act at the site of bone fracture or lowered bone density to enhance or accelerate bone formation, thereby improving the prognosis of a patient. The combination may be used to treat fractures, to prevent or treat osteoporosis, to improve outcomes for bone replacement and to prevent or treat bone loss due to other physiologic disorders. | 10-16-2008 |
